http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NL-301091-I1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_956d70011ddc1d5015cd657f4bad88bb |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
filingDate | 2021-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | NL-301091-I1 |
titleOfInvention | delafloxacin, or any salt or esters thereof, including delafloxacin meglumine |
priorityDate | 2008-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.